MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Written by / Agency / Source: Polaris Health Directions
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Polaris Awarded Grant to Improve Patient Engagement in Treatment for Chemical Dependency - Polaris, in collaboration with the New Hope Foundation, is enhancing its chemical dependency outcomes management system to better predict and improve engagement rates in treatment
Polaris Awarded Grant to Improve Patient Engagement in Treatment for Chemical Dependency

 

NewswireToday - /newswire/ - Langhorne, PA, United States, 2012/08/06 - Polaris, in collaboration with the New Hope Foundation, is enhancing its chemical dependency outcomes management system to better predict and improve engagement rates in treatment.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Polaris Health Directions has been at the forefront of developing technology to improve substance abuse treatment outcomes for more than a decade. With new funding from the National Institute on Drug Abuse (NIDA), the company, in partnership with the New Hope Foundation, is now preparing to refine its chemical dependency outcomes management system, Polaris-CD, to predict and improve engagement rates in treatment--integral to positive outcomes. Experts on Motivational Enhancement Therapy from Yale University are also collaborating.

The first phase of this project will involve three enhancements to the existing Polaris-CD. Using data from more than 2,000 patients treated at New Hope and at Kaiser Permanente, in southern California, the research team will derive a predictive model to indicate whether a patient is likely to engage in treatment. This model will help counselors identify early those patients who are at highest risk for treatment failure.

Additionally, the team will develop and field test a motivational, personalized feedback report for patients. This report will include information on the severity of the patient’s drug or alcohol use (as compared to other patients in chemical depedendency treatment); the importance of the recommended services matched to a patient’s particular set of needs; and motivational messages that are tailored to the patient’s readiness for change and other risk factors.

The third modification to Polaris-CD is the addition of a guide for implementing into routine treatment two evidence-based practices: matching patients directly to services (not programs) and motivational enhancement therapy. While research has demonstrated that these practices are effective in improving outcomes, barriers to implementation have hindered widespread adoption. The enhanced Polaris-CD, with its Web-based platform and strong scientific foundation, will be the much needed link between research and practice.

Polaris-CD is a HIPAA-compliant, EHR-compatible solution that helps treatment providers identify which services are most cost-effective for a particular patient, determine whether treatment is working and if there is a high risk for dropout or relapse. Its development was funded by NIDA, and it is currently in use at chemical dependency treatment programs around the nation.

The project described was supported by Award Number 1R43DA032180 from the National Institute on Drug Abuse. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health.

About Polaris Health Directions

At Polaris, we recognize that organizations cannot manage what they do not measure. Many behavioral health care providers and payers may not be collecting and analyzing enough of the right data to answer basic questions about the cost-effectiveness of the care they offer. Polaris's advanced technology and science driven assessment systems are designed to capture the clinical data essential to quality improvement and enhanced organizational management. Polaris solutions provide advanced analytics to help you improve and demonstrate to your customers the value of your care. With a focus on prediction, Polaris solutions do more than describe clinical change. Our systems also indicate if treatment is likely to have a positive result. Helping you make better decisions in the present by anticipating the future will be the difference in reducing your costs while improving patient care.

About New Hope Foundation

New Hope Foundation (newhopefoundation.org) is a non-profit corporation (501©(3)) dedicated to serving those most in need of treatment for alcoholism, drug addiction and compulsive gambling. We provide state of the art care under license by the state of New Jersey and with the ongoing accreditation from the Commission on Accreditation of Rehabilitation Facilities (CARF). Private citizens, businesses and organizations, from both the private and public sector, help to support our mission to serve those in need with little ability to pay. We serve those with health insurance, and offer other options so our clients can afford to pay the reasonable fees we charge for high quality care. New Hope Foundation is one of New Jersey's largest agencies.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Polaris Health Directions

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Polaris Awarded Grant to Improve Patient Engagement in Treatment for Chemical Dependency

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Jesse Nankin - PolarisHealth.com 
215-359-3901 moreinfo[.]polarishealth.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Polaris Health Directions securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Polaris Health Directions / Company Profile


Read Health / Surgery Most Recent Related Newswires:

South Carolina’s Humimic Medical Arming Healthcare Workers for the COVID-19 War
SCBIO Executive Erin Ford Appointed to South Carolina District Export Council for 2020-2021
University of the Ryukyus and NEC Discover a Novel Diagnostic Biomarker for Acute Adult T-cell Leukemia/lymphoma
Change Healthcare Recognized by Frost & Sullivan for Accelerating Claims Processing with its Intelligent Healthcare Network™ Blockchain Technology
SCBIO CEO Sam Konduros Named to South Carolina Chamber Executive Committee
Frost & Sullivan Defines Top Femtech Global Opportunities by 2024
Frost & Sullivan Highlights on Impact of the Coronavirus on Business
Global Healthcare to Soar Above Trillion in 2020 with Consumerism and Outcome-based Care Models Finds Frost & Sullivan
Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies Reports Frost & Sullivan
PointClickCare Integrated Care Coordination Platform Applauded by Frost & Sullivan
Inkwood Research Publishes Global Genetic Testing Market Forecast 2019-2027
NEC and VAXIMM Announce Collaboration to Advance Personalized Neoantigen Cancer Vaccines
Alopecia Hair Loss Treatment Market is Advancing At A CAGR of 5.51% by 2027 According to Inkwood Research
Frost & Sullivan Distinguishes Inovalon as Company of the Year for Advancing the Healthcare Industry by Harnessing Massive-Scale Data
South Carolina Life Sciences Industry Honors USC’s Dr. Harris Pastides, AVX Corporation

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  RightITnow, Inc.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)